News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
386,845 Results
Type
Article (26211)
Company Profile (60)
Press Release (360574)
Multimedia
Podcasts (26)
Webinars (7)
Section
Business (105650)
Career Advice (455)
Deals (17233)
Drug Delivery (51)
Drug Development (48026)
Employer Resources (47)
FDA (12324)
Job Trends (8489)
News (188191)
Policy (19566)
Tag
Academia (1764)
Accelerated approval (3)
Adcomms (8)
Allergies (74)
Alliances (27219)
ALS (60)
Alzheimer's disease (816)
Antibody-drug conjugate (ADC) (58)
Approvals (12385)
Artificial intelligence (175)
Autoimmune disease (10)
Automation (4)
Bankruptcy (148)
Best Places to Work (6926)
BIOSECURE Act (5)
Biosimilars (37)
Biotechnology (40)
Bladder cancer (60)
Brain cancer (17)
Breast cancer (203)
Cancer (1469)
Cardiovascular disease (122)
Career advice (412)
Career pathing (13)
CAR-T (72)
Cell therapy (206)
Cervical cancer (14)
Clinical research (40928)
Collaboration (456)
Compensation (139)
Complete response letters (9)
COVID-19 (1500)
CRISPR (14)
C-suite (151)
Cystic fibrosis (43)
Data (1609)
Decentralized trials (2)
Denatured (18)
Depression (31)
Diabetes (180)
Diagnostics (3554)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (53)
Drug pricing (57)
Drug shortages (21)
Duchenne muscular dystrophy (56)
Earnings (37551)
Editorial (22)
Employer branding (6)
Employer resources (44)
Events (52397)
Executive appointments (459)
FDA (13385)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (418)
Gene editing (41)
Generative AI (11)
Gene therapy (133)
GLP-1 (411)
Government (3044)
Grass and pollen (3)
Guidances (97)
Healthcare (12286)
Huntington's disease (10)
IgA nephropathy (16)
Immunology and inflammation (44)
Indications (19)
Infectious disease (1573)
Inflammatory bowel disease (84)
Inflation Reduction Act (4)
Influenza (29)
Intellectual property (52)
Interviews (40)
IPO (7198)
IRA (19)
Job creations (1854)
Job search strategy (383)
Kidney cancer (7)
Labor market (13)
Layoffs (173)
Leadership (4)
Legal (3688)
Liver cancer (57)
Lung cancer (234)
Lymphoma (101)
Machine learning (4)
Management (17)
Manufacturing (111)
MASH (57)
Medical device (12921)
Medtech (12924)
Mergers & acquisitions (10354)
Metabolic disorders (452)
Multiple sclerosis (57)
NASH (11)
Neurodegenerative disease (51)
Neuropsychiatric disorders (9)
Neuroscience (1165)
NextGen: Class of 2025 (3958)
Non-profit (2825)
Now hiring (17)
Obesity (222)
Opinion (72)
Ovarian cancer (56)
Pain (67)
Pancreatic cancer (56)
Parkinson's disease (92)
Partnered (12)
Patents (120)
Patient recruitment (84)
Peanut (37)
People (35145)
Pharmaceutical (17)
Pharmacy benefit managers (12)
Phase I (11716)
Phase II (17734)
Phase III (14557)
Pipeline (778)
Policy (62)
Postmarket research (1680)
Preclinical (3665)
Press Release (18)
Prostate cancer (78)
Psychedelics (17)
Radiopharmaceuticals (161)
Rare diseases (186)
Real estate (2881)
Recruiting (16)
Regulatory (14324)
Reports (17)
Research institute (1614)
Resumes & cover letters (48)
Rett syndrome (2)
RNA editing (2)
RSV (20)
Schizophrenia (54)
Series A (69)
Series B (50)
Service/supplier (3)
Sickle cell disease (22)
Special edition (4)
Spinal muscular atrophy (102)
Sponsored (13)
Startups (2168)
Stomach cancer (8)
Supply chain (38)
Tariffs (16)
The Weekly (8)
Vaccines (368)
Venture capitalists (13)
Weight loss (142)
Women's health (18)
Worklife (4)
Date
Today (91)
Last 7 days (499)
Last 30 days (1632)
Last 365 days (18495)
2025 (6529)
2024 (20012)
2023 (22922)
2022 (30918)
2021 (33292)
2020 (32492)
2019 (28623)
2018 (21961)
2017 (19169)
2016 (18341)
2015 (21476)
2014 (16248)
2013 (13460)
2012 (14588)
2011 (14820)
2010 (13345)
Location
Africa (358)
Alabama (17)
Alaska (2)
Arizona (121)
Arkansas (10)
Asia (24944)
Australia (3977)
California (3187)
Canada (1281)
China (382)
Colorado (168)
Connecticut (176)
Delaware (123)
Europe (49219)
Florida (577)
Georgia (136)
Idaho (33)
Illinois (364)
India (14)
Indiana (231)
Iowa (3)
Japan (125)
Kansas (74)
Kentucky (12)
Louisiana (8)
Maine (27)
Maryland (649)
Massachusetts (2229)
Michigan (109)
Minnesota (279)
Mississippi (2)
Missouri (52)
Montana (18)
Nebraska (18)
Nevada (36)
New Hampshire (60)
New Jersey (1164)
New Mexico (9)
New York (985)
North Carolina (586)
North Dakota (4)
Northern California (1401)
Ohio (134)
Oklahoma (3)
Oregon (23)
Pennsylvania (865)
Puerto Rico (7)
Rhode Island (24)
South America (529)
South Carolina (23)
Southern California (1224)
Tennessee (79)
Texas (572)
United States (13292)
Utah (115)
Virginia (82)
Washington D.C. (42)
Washington State (235)
West Virginia (3)
Wisconsin (43)
386,845 Results for "mellon medical bv".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioVersys Announces Important BV100 Patent Granted by Chinese Patent Office
March 31, 2025
·
5 min read
Press Releases
BioVersys to Present BV100 Phase 2 Data at 35th ESCMID Global 2025
April 8, 2025
·
10 min read
Press Releases
BioVersys to Host Virtual KOL Event to Discuss BV100 Phase 2 Ventilator Associated Pneumonia (VABP) Study Against Carbapenem Resistant Acinetobacter on May 7, 2025
April 28, 2025
·
4 min read
Press Releases
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES LAUNCH OF AUTHORIZED GENERIC OF Maxitrol® (Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension)
April 25, 2025
·
3 min read
Press Releases
Pharming Technologies B.V. increases its ownership in Abliva AB (publ) to 92.70 percent
February 21, 2025
·
11 min read
Press Releases
Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV
December 30, 2024
·
5 min read
Press Releases
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), PRESENTING PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY ANNUAL MEETING
April 24, 2025
·
4 min read
Press Releases
MilliporeSigma Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio
January 7, 2025
·
3 min read
Press Releases
MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio
December 17, 2024
·
5 min read
Press Releases
Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H’s REACT Program
December 17, 2024
·
6 min read
1 of 38,685
Next
